Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Capital One
COF
$130B
| $110M | 0.08% |
1,184,944
-1,136,542
| -49% | -$112M |
|
227
Maximus
MMS
$3.31B
| $110M | 0.08% |
1,501,345
-1,312,343
| -47% | -$84.7M |
|
|
TWNK
228
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $110M | 0.08% |
4,898,377
-7,641,547
| -61% | -$192M |
|
229
Telus
TU
$16.7B
| $109M | 0.08% |
5,650,830
-4,559,412
| -45% | -$94.2M |
|
230
EnerSys
ENS
$6.69B
| $108M | 0.08% |
1,456,661
-1,475,603
| -50% | -$103M |
|
231
Travere Therapeutics
TVTX
$5.2B
| $107M | 0.08% |
5,091,285
-2,733,685
| -35% | -$57.9M |
|
232
Alight
ALIT
$523M
| $106M | 0.08% |
635,324
-442,875
| -41% | -$73.8M |
|
233
ITT
ITT
$17.8B
| $106M | 0.08% |
1,302,212
-1,297,902
| -50% | -$101M |
|
234
Snowflake
SNOW
$93.7B
| $104M | 0.07% |
727,221
-951,409
| -57% | -$145M |
|
235
PagerDuty
PD
$795M
| $104M | 0.07% |
3,914,930
-3,994,002
| -50% | -$94.3M |
|
236
CBRE Group
CBRE
$43.1B
| $103M | 0.07% |
1,339,358
-1,307,604
| -49% | -$96.6M |
|
237
Royalty Pharma
RPRX
$26.6B
| $103M | 0.07% |
2,600,501
-2,927,661
| -53% | -$122M |
|
238
Dollar Tree
DLTR
$24.4B
| $103M | 0.07% |
725,514
-626,132
| -46% | -$93.2M |
|
239
Frontdoor
FTDR
$5.22B
| $102M | 0.07% |
4,909,392
-5,885,410
| -55% | -$129M |
|
240
Nordson
NDSN
$16.9B
| $97.6M | 0.07% |
410,702
-514,826
| -56% | -$118M |
|
|
ISEE
241
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $97.5M | 0.07% |
4,553,904
-5,673,078
| -55% | -$121M |
|
242
Vistra
VST
$50.1B
| $97.2M | 0.07% |
4,189,078
+1,112,034
| +36% | +$25.7M |
|
243
Healthpeak Properties
DOC
$15.7B
| $97M | 0.07% |
3,872,715
+3,712,383
| +2,315% | +$90.2M |
|
|
AQUA
244
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $95.7M | 0.07% |
2,416,866
-2,242,438
| -48% | -$88.2M |
|
|
WNS
245
DELISTED
WNS Holdings
WNS
| $94.5M | 0.07% |
1,181,346
-1,352,936
| -53% | -$112M |
|
246
Penumbra
PEN
$12.6B
| $94M | 0.07% |
422,688
-504,630
| -54% | -$98.7M |
|
247
SkinHealth Systems
SKIN
$90.5M
| $93.6M | 0.07% |
10,289,105
-10,915,001
| -51% | -$118M |
|
248
Selective Insurance
SIGI
$5.63B
| $93M | 0.07% |
1,049,870
-1,105,404
| -51% | -$101M |
|
249
Zurn Elkay Water Solutions
ZWS
$8.23B
| $92.4M | 0.07% |
4,368,285
-4,402,469
| -50% | -$104M |
|
|
SUM
250
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $92.3M | 0.07% |
3,252,615
-3,187,210
| -49% | -$87.8M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.